Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals's Group Entities Data Preview
As of Invalid Date, Tracenable has captured detailed data on Alnylam Pharmaceuticals's corporate ownership structure, offering an in-depth view of its significant subsidiaries and their importance within the group. a
The dataset includes information on 25 subsidiaries, identified as material based on their financial importance, operational scale, or strategic contribution to Alnylam Pharmaceuticals's consolidated operations. a
Tracenable's data also records the effective ownership percentages that Alnylam Pharmaceuticals holds across these entities, providing transparency into its corporate control, ownership hierarchy, and group governance practices. a
| Entity Name | Country | Type | Ownership | LEI | PermID |
|---|---|---|---|---|---|
Copy restricted. Please purchase to unlock this data.  a | USA | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | USA | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | GBR | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | USA | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | USA | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | ARG | Subsidiary | 95% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | AUS | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | AUT | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | BEL | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | BRA | Subsidiary | 99% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | BMU | Subsidiary | 100% | 0000000 | 0000000 |
Copy restricted. Please purchase to unlock this data.  a | CAN | Subsidiary | 100% | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
0000000 | 0000000 | 0000000 | 0000000 | 0000000 | 0000000 |
| Showing 12 out of 25 entities. Get complete coverage in the full dataset. | |||||
Verified Sources Behind Alnylam Pharmaceuticals’s Group Entities Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Alnylam Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.
Insights into Alnylam Pharmaceuticals's Group Entities Location
Tracenable's group entities dataset provides geographic insights into Alnylam Pharmaceuticals's significant subsidiaries, revealing their location around the world. a
In total, the Alnylam Pharmaceuticals group includes 25 significant subsidiaries distributed across 20 countries, illustrating the company's governance network, operational footprint, and geographical consolidation structure. a
This visualization highlights the geographical distribution of Alnylam Pharmaceuticals's corporate structure, helping assess its international exposure, operational reach, and cross-border governance landscape. a
How geographically diverse is Alnylam Pharmaceuticals's corporate structure?
In 2024, Tracenable identified that the Alnylam Pharmaceuticals group consisted of 25 significant subsidiaries, located across 20 countries. a
This represents a focused geographic presence, reflecting the company's core operational centers or key strategic markets rather than a full view of its global entity network. a
What does the geographic footprint of Alnylam Pharmaceuticals reveal about its business operations?
Alnylam Pharmaceuticals's significant subsidiaries are primarily located in Europe and North America, which together host 80% of its material entities. a
This concentration suggests that the company's strategic and operational priorities are centered in these key markets, consistent with its focus on financially material or high-impact operations.
How transparent is Alnylam Pharmaceuticals about its group entities and ownership structure?
Alnylam Pharmaceuticals exhibits a limited level of transparency concerning its corporate ownership structure.
The disclosure covers only a small number of significant subsidiaries, typically those with material financial or operational relevance. a
Without full group hierarchy or equity details, it offers a restricted view of Alnylam Pharmaceuticals's broader ownership network, making it harder to assess the company's consolidated structure or cross-entity control.
Does Alnylam Pharmaceuticals maintain entities in low-tax or offshore jurisdictions?
Yes. Tracenable's data shows that 1 entities ( 4%) are registered in jurisdictions commonly classified as low-tax or offshore financial centers, such as Bermuda. a
This may indicate tax optimization strategies or the use of special-purpose vehicles (SPVs) within Alnylam Pharmaceuticals's ownership structure.